WENDY PETTIT: Open Payments
NPI 1205871589 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,982 in 111 payments from 14 companies in 2025. Trend: 2023 $2,303 · 2024 $3,148 · 2025 $1,982
Food & beverage: $1,982
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $380 |
| ABBVIE INC. | 18 | $285 |
| Vanda Pharmaceuticals Inc. | 8 | $284 |
| Lundbeck LLC | 11 | $244 |
| Axsome Therapeutics, Inc. | 12 | $181 |
| Teva Pharmaceuticals USA, Inc. | 11 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Supernus Pharmaceuticals, Inc. | 5 | $89 |
| Alkermes, Inc. | 3 | $68 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FANAPT, Auvelity, AUSTEDO XR, TRINTELLIX, Qelbree.
Industry payments across NY — which companies pay providers there.
